1. Bevacizumab increases the risk of infections in cancer patients: A systematic review and pooled analysis of 41 randomized controlled trials. Issue 3 (June 2015) Authors: Qi, Wei-Xiang; Fu, Shen; Zhang, Qing; Guo, Xiao-Mao Journal: Critical reviews in oncology/hematology Issue: Volume 94:Issue 3(2015) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗